HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kelsey Natsuhara Selected Research

lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)

12/2022Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kelsey Natsuhara Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
10/2019 - 01/2017
1Infections
12/2022
1Lymphopenia (Lymphocytopenia)
12/2022
1Multiple Myeloma
12/2022
1Neutropenia
12/2022
1Neoplasm Micrometastasis
10/2019
1Neoplasms (Cancer)
10/2019
1Inflammation (Inflammations)
01/2017

Drug/Important Bio-Agent (IBA)

1Chimeric Antigen ReceptorsIBA
12/2022
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2022
1B-Cell Maturation AntigenIBA
12/2022
1lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)IBA
12/2022
1Matrix Metalloproteinases (MMPs)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017

Therapy/Procedure

1Therapeutics
12/2022
1Neoadjuvant Therapy
10/2019
1Adjuvant Chemotherapy
01/2017
1Drug Therapy (Chemotherapy)
01/2017